Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$382M |
| 2 |
Pfizer
PFE
|
+$266M |
| 3 |
Electronic Arts
EA
|
+$240M |
| 4 |
Eli Lilly
LLY
|
+$221M |
| 5 |
Colgate-Palmolive
CL
|
+$216M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$358M |
| 2 |
Comcast
CMCSA
|
+$263M |
| 3 |
Meta Platforms (Facebook)
META
|
+$258M |
| 4 |
AET
Aetna Inc
AET
|
+$257M |
| 5 |
Tesla
TSLA
|
+$189M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.14% |
| 2 | Technology | 13.55% |
| 3 | Financials | 11.85% |
| 4 | Consumer Staples | 10.18% |
| 5 | Industrials | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1526
Home BancShares
HOMB
$6.31B
| $6.57M | 0.01% |
+263,984
| New | +$6.58M |
|
1527
La-Z-Boy
LZB
$1.65B
| $6.55M | 0.01% |
+201,676
| New | +$5.66M |
|
1528
Saga Communications
SGA
$56.1M
| $6.55M | 0.01% |
143,258
+5,058
| +4% | +$251K |
|
|
GSS
1529
DELISTED
Golden Star Resources Ltd.
GSS
| $6.55M | 0.01% |
2,013,898
-82,860
| -4% | -$295K |
|
|
EMCI
1530
DELISTED
EMC INS Group Inc
EMCI
| $6.54M | 0.01% |
235,350
+7,978
| +4% | +$219K |
|
|
TVTY
1531
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $6.52M | 0.01% |
163,589
-273,300
| -63% | -$9.14M |
|
|
CDR
1532
DELISTED
Cedar Realty Trust, Inc
CDR
| $6.51M | 0.01% |
203,470
-38,591
| -16% | -$1.31M |
|
|
ESSA
1533
DELISTED
ESSA Bancorp
ESSA
| $6.49M | 0.01% |
440,700
+5,800
| +1% | +$86.1K |
|
|
OME
1534
DELISTED
Omega Protein
OME
| $6.49M | 0.01% |
362,300
+39,874
| +12% | +$745K |
|
1535
Griffon
GFF
$4.29B
| $6.48M | 0.01% |
295,300
-300
| -0.1% | -$6.9K |
|
1536
Century Casinos
CNTY
$32.6M
| $6.47M | 0.01% |
878,500
+220,300
| +33% | +$1.73M |
|
1537
Armstrong World Industries
AWI
$7.62B
| $6.46M | 0.01% |
140,464
-160,336
| -53% | -$7.19M |
|
|
EPAY
1538
DELISTED
Bottomline Technologies Inc
EPAY
| $6.46M | 0.01% |
251,300
+8,158
| +3% | +$200K |
|
1539
Mistras Group
MG
$490M
| $6.45M | 0.01% |
293,700
-16,800
| -5% | -$362K |
|
|
CALL
1540
DELISTED
magicJack VocalTec Ltd
CALL
| $6.44M | 0.01% |
894,768
-7,868
| -0.9% | -$60K |
|
|
MDRX
1541
DELISTED
Veradigm Inc. Common Stock
MDRX
| $6.44M | 0.01% |
+504,567
| New | +$6.13M |
|
1542
Kennametal
KMT
$2.71B
| $6.43M | 0.01% |
+171,900
| New | +$6.73M |
|
1543
Moelis & Co
MC
$5.1B
| $6.42M | 0.01% |
165,144
-278,716
| -63% | -$10.4M |
|
|
AMRI
1544
DELISTED
Albany Molecular Research Inc
AMRI
| $6.41M | 0.01% |
295,542
+147,200
| +99% | +$2.67M |
|
|
GMS
1545
DELISTED
GMS Inc
GMS
| $6.4M | 0.01% |
227,700
+9,200
| +4% | +$309K |
|
1546
Coca-Cola Consolidated
COKE
$13B
| $6.37M | 0.01% |
278,270
-94,730
| -25% | -$2.05M |
|
1547
CytomX Therapeutics
CTMX
$701M
| $6.37M | 0.01% |
410,900
+176,100
| +75% | +$2.65M |
|
|
PAMT
1548
PAMT Corp
PAMT
$360M
| $6.36M | 0.01% |
1,342,800
-86,800
| -6% | -$376K |
|
|
ELOS
1549
DELISTED
Syneron Medical Ltd
ELOS
| $6.36M | 0.01% |
580,780
-523,800
| -47% | -$5.74M |
|
1550
Associated Banc-Corp
ASB
$5.86B
| $6.36M | 0.01% |
252,316
-210,863
| -46% | -$5.18M |
|
Similar funds
Renaissance Technologies's Q2 2017 Portfolio in Review
As of Q2 2017, Renaissance Technologies held 3,586 positions worth $78.4B, up 9.5% from $71.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Renaissance Technologies deployed $4.59B of net new capital in Q2 2017, opening 398 new positions and adding to 1,648 existing holdings. Its largest new stake was Pfizer: 8,421,609 shares worth $268M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Comcast, an estimated $263M trimmed.
- Renaissance Technologies's largest Q2 2017 buy was Pfizer: 8,421,609 shares worth $268M.
- Renaissance Technologies added most to Bristol-Myers Squibb in Q2 2017, an estimated $382M increase.
- Renaissance Technologies's biggest Q2 2017 reduction was Comcast, cutting an estimated $263M.
- Renaissance Technologies fully exited Booking.com in Q2 2017, selling an estimated $358M.
- Renaissance Technologies's ten largest holdings make up 9% of its $78.4B portfolio in Q2 2017.
- Renaissance Technologies opened 398 new positions and closed 418 in Q2 2017.
- Renaissance Technologies's portfolio value rose 9.5% quarter-over-quarter to $78.4B.
Based on Renaissance Technologies's 13F filing for Q2 2017, filed 11 Aug 2017.